ICU Medical, Inc. (ICUI)
170.81
-2.14
(-1.24%)
USD |
NASDAQ |
Sep 01, 16:00
171.50
+0.69
(+0.40%)
After-Hours: 07:00
ICU Medical Research and Development Expense (Annual) : 87.50M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 87.50M |
| December 31, 2024 | 88.62M |
| December 31, 2023 | 85.34M |
| December 31, 2022 | 92.98M |
| December 31, 2021 | 47.50M |
| December 31, 2020 | 42.95M |
| December 31, 2019 | 48.61M |
| December 31, 2018 | 52.87M |
| December 31, 2017 | 51.25M |
| December 31, 2016 | 12.96M |
| December 31, 2015 | 15.71M |
| December 31, 2014 | 18.33M |
| December 31, 2013 | 12.41M |
| December 31, 2012 | 10.63M |
| December 31, 2011 | 8.588M |
| December 31, 2010 | 4.678M |
| December 31, 2009 | 2.645M |
| Date | Value |
|---|---|
| December 31, 2008 | 4.822M |
| December 31, 2007 | 8.111M |
| December 31, 2006 | 7.659M |
| December 31, 2005 | 4.417M |
| December 31, 2004 | 2.176M |
| December 31, 2003 | 1.757M |
| December 31, 2002 | 1.472M |
| December 31, 2001 | 1.188M |
| December 31, 2000 | 1.48M |
| December 31, 1999 | 1.214M |
| December 31, 1998 | 1.048M |
| December 31, 1997 | 1.261M |
| December 31, 1996 | 0.7904M |
| December 31, 1995 | 0.1638M |
| December 31, 1994 | 0.2007M |
| December 31, 1993 | 0.1066M |
| December 31, 1992 | 0.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Baxter International, Inc. | 503.00M |
| Becton, Dickinson & Co. | 1.265B |
| Boston Scientific Corp. | 2.052B |
| Glaukos Corp. | 150.61M |
| Medline, Inc. | 80.00M |